IRON Earnings & Financial Statements
Disc Medicine, Inc.
$57.44
+$1.70(+3.05%)
39
Overall
55
Value
27
Tech
36
Quality
Market Cap
$2.14B
Volume
57.61K
52W Range
$40.00 - $99.50
Target Price
$103.17
IRON earnings and financial statements: Disc Medicine, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
IRON Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cost of revenue | - | - | - | - | $600.0K |
| Operating income | -$236.02M | -$129.72M | -$91.13M | -$47.48M | -$30.93M |
| EBITDA | -$207.94M | -$108.27M | -$76.23M | -$47.39M | -$30.90M |
| Net income | -$212.18M | -$109.36M | -$76.43M | -$46.83M | -$35.97M |
| EPS (diluted) | $-6.01 | $-3.96 | $-3.42 | $-45.05 | $-17.80 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $806.88M | $496.77M | $368.00M | $200.21M | $92.41M |
| Total liabilities | $67.05M | $53.19M | $22.88M | $23.61M | $14.76M |
| Shareholders’ equity | $739.83M | $443.59M | $345.12M | $176.60M | -$64.20M |
| Cash and equivalents | $91.14M | $192.43M | $360.38M | $194.61M | $88.04M |
| Long-term debt | $30.41M | $29.87M | $1.44M | $1.03M | $1.33M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$180.39M | -$93.93M | -$73.46M | -$42.25M | -$27.53M |
| Capital expenditure | -$933.0K | -$505.0K | -$89.0K | -$151.0K | -$68.0K |
| Free cash flow | -$181.33M | -$94.43M | -$73.55M | -$42.40M | -$27.60M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IRON | $57.44 | +3.0% | 57.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |